CareLit Fachartikel

The DNA-binding protein YB-1 is a direct MYCN target and influences repair and resistance in neuroblastoma cell lines

S Degen, S Kuhfittig-Kulle, JH Schulte, F Westermann, A Schramm, A Eggert, K Astrahantseff · Klinische Pädiatrie · 2010 · Heft 05

Dokument
864713
CareLit-ID
Jahr
2010
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
S Degen, S Kuhfittig-Kulle, JH Schulte, F Westermann, A Schramm, A Eggert, K Astrahantseff
Ausgabe
Heft 05 / 2010
Seiten
–
Erschienen: 2010-05-07 00:00:00
ISSN
0300-8630

Zusammenfassung

YB-1 regulates both gene transcription and translation, and increased YB-1 expression and nuclear localization has been associated with aggressive cancer phenotypes. We examined YB-1 expression, assessed the effect of YB-1 knockdown on cell viability and repair capacity and transcriptional control via MYCN in neuroblastoma (NB) cell models. YB-1 was expressed in NB cell lines, and expression was elevated in a cisplatin-resistant cell line. Cisplatin treatment induced YB-1 expression and nuclear translocation, and YB-1 knockdown increased sensitivity to cisplatin and the number of γH2AX foci, indicating reduced r…

Schlagworte

Klinische Pädiatrie